These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2285688)

  • 1. A case of cerebrotendinous xanthomatosis. II: The sterol content of a cataractous lens.
    McKenna P; Morgan SJ; Bosanquet RC; Laker MF
    Br J Ophthalmol; 1990 Oct; 74(10):629-30. PubMed ID: 2285688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolism of cholestanol, cholesterol, and bile acids in cerebrotendinous xanthomatosis.
    Salen G; Grundy SM
    J Clin Invest; 1973 Nov; 52(11):2822-35. PubMed ID: 4355999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis.
    Salen G; Shefer S; Tint GS
    Gastroenterology; 1984 Aug; 87(2):276-83. PubMed ID: 6735073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of 5 alpha-cholestane-3 beta, 7 alpha-diol from bile of patients with cerebrotendinous xanthomatosis. Inefficiency of this steroid as a precursor to cholestanol.
    Björkhem I; Buchmann MS; Skrede S
    Biochim Biophys Acta; 1983 Sep; 753(2):220-6. PubMed ID: 6412759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of plant sterols and cholesterol precursors in cerebrotendinous xanthomatosis.
    Kuriyama M; Fujiyama J; Kasama T; Osame M
    J Lipid Res; 1991 Feb; 32(2):223-9. PubMed ID: 2066659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biosynthesis of 5 -cholestan-3 -ol in cerebrotendinous xanthomatosis.
    Salen G; Polito A
    J Clin Invest; 1972 Jan; 51(1):134-40. PubMed ID: 4550120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Laboratory diagnosis of a rare congenital neurodegenerative disease: cerebrotendinous xanthomatosis].
    Varga VE; Katkó M; Harangi J; Balogh I; Kapás I; Madar L; Seres I; Molnár MJ; Paragh G; Kovács GG; Harangi M
    Orv Hetil; 2014 May; 155(21):811-6. PubMed ID: 24836315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel route for the biosynthesis of cholestanol, and its significance for the pathogenesis of cerebrotendinous xanthomatosis.
    Skrede S; Bjørkhem I
    Scand J Clin Lab Invest Suppl; 1985; 177():15-21. PubMed ID: 3865344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel pathway for biosynthesis of cholestanol with 7 alpha-hydroxylated C27-steroids as intermediates, and its importance for the accumulation of cholestanol in cerebrotendinous xanthomatosis.
    Skrede S; Björkhem I; Buchmann MS; Hopen G; Fausa O
    J Clin Invest; 1985 Feb; 75(2):448-55. PubMed ID: 3919058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capillary gas chromatographic determination of cholestanol/cholesterol ratio in biological fluids. Its potential usefulness for the follow-up of some liver diseases and its lack of specificity in diagnosing CTX (cerebrotendinous xanthomatosis).
    Koopman BJ; van der Molen JC; Wolthers BG; de Jager AE; Waterreus RJ; Gips CH
    Clin Chim Acta; 1984 Mar; 137(3):305-15. PubMed ID: 6421514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of accumulation of cholesterol and cholestanol in tendons and the role of sterol 27-hydroxylase (CYP27A1).
    von Bahr S; Movin T; Papadogiannakis N; Pikuleva I; Rönnow P; Diczfalusy U; Björkhem I
    Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1129-35. PubMed ID: 12117727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis. Effect of chenodeoxycholic acid.
    Salen G; Berginer V; Shore V; Horak I; Horak E; Tint GS; Shefer S
    N Engl J Med; 1987 May; 316(20):1233-8. PubMed ID: 3106810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations.
    Moghadasian MH; Salen G; Frohlich JJ; Scudamore CH
    Arch Neurol; 2002 Apr; 59(4):527-9. PubMed ID: 11939886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isotopomer spectral analysis of intermediates of cholesterol synthesis in patients with cerebrotendinous xanthomatosis.
    Clarenbach JJ; Lindenthal B; Dotti MT; Federico A; Kelleher JK; von Bergmann K
    Metabolism; 2005 Mar; 54(3):335-44. PubMed ID: 15736111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical diagnosis of cerebrotendinous xanthomatosis using reversed phase thin layer chromatography.
    Kasama T; Seyama Y
    J Biochem; 1986 Mar; 99(3):771-5. PubMed ID: 3086296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type IIa hyperlipoproteinemia masquerading as cerebrotendinous xanthomatosis.
    Ijichi S; Ijichi N; Niina K; Kuriyama M; Izumo S; Nakamura F; Osame M
    J Neurol Sci; 1989 Dec; 94(1-3):101-5. PubMed ID: 2614461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrotendinous xanthomatosis.
    Björkhem I
    Curr Opin Lipidol; 2013 Aug; 24(4):283-7. PubMed ID: 23759795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the mechanism of biosynthesis of cholestanol from 7 alpha-hydroxycholesterol.
    Buchmann MS; Björkhem I; Lund AM; Skrede S
    Scand J Clin Lab Invest Suppl; 1986; 184():41-6. PubMed ID: 3109015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrotendinous xanthomatosis: clinical course, genotypes and metabolic backgrounds.
    Moghadasian MH
    Clin Invest Med; 2004 Feb; 27(1):42-50. PubMed ID: 15061585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholestanol metabolism in patients with cerebrotendinous xanthomatosis: absorption, turnover, and tissue deposition.
    Bhattacharyya AK; Lin DS; Connor WE
    J Lipid Res; 2007 Jan; 48(1):185-92. PubMed ID: 17012751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.